These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 887048)

  • 21. [Direct determination of intestinal absorption of tritium-labelled cardiac glycosides by measurement of portal and arterial concentrations and volume of portal vein flow in guinea pigs].
    Haass A; Peters T
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):343. PubMed ID: 4253785
    [No Abstract]   [Full Text] [Related]  

  • 22. [Correction of the incorrectly measured Hatcher-Brody optimal titer of cardiotonic steroids. Determination of the molar optimal titer at long survival time].
    Vogel G
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(3):320. PubMed ID: 4242454
    [No Abstract]   [Full Text] [Related]  

  • 23. [Metabolism and kinetics of -acetyldigoxin].
    Ruiz-Torres A; Burmeister H
    Klin Wochenschr; 1972 Feb; 50(4):191-5. PubMed ID: 5011551
    [No Abstract]   [Full Text] [Related]  

  • 24. Current status of cardiac glycoside drug interactions.
    Hooymans PM; Merkus FW
    Clin Pharm; 1985; 4(4):404-13. PubMed ID: 2412751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Gitoformate and digitoxin as alternatives to kidney-dependent glycosides in the therapy of cardiac insufficiency].
    Rietbrock N; Woodcock BG; Hrazdil U
    Arzneimittelforschung; 1984; 34(8):915-7. PubMed ID: 6541927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Biochemical principles of the development of new cardiac drugs of the digitalis type].
    Repke KR
    Pharmazie; 1972 Nov; 27(11):693-701. PubMed ID: 4265944
    [No Abstract]   [Full Text] [Related]  

  • 27. [Cumulative effect of cardiac glycosides. (Review)].
    Angarskaia MA; Liubartseva LA; Sokolova VE
    Farmakol Toksikol; 1969; 32(6):745-6. PubMed ID: 4909670
    [No Abstract]   [Full Text] [Related]  

  • 28. [Extracardiac effects of digitalis glycosides].
    Heidenreich O
    Verh Dtsch Ges Herz Kreislaufforsch; 1982; 48():47-55. PubMed ID: 6314692
    [No Abstract]   [Full Text] [Related]  

  • 29. [On the pharmacokinetics of peruvoside. I. Comparative clinical and experimental animal studies].
    Hundeshagen H; Zeidler U; Fabel H; Garbe A; Nowak H
    Arzneimittelforschung; 1968 Dec; 18(12):1592-6. PubMed ID: 5756259
    [No Abstract]   [Full Text] [Related]  

  • 30. 3-Epimerisation of digoxigenin in the rat.
    Thomas RE; Wright SE
    J Pharm Pharmacol; 1965 Jul; 17(7):459. PubMed ID: 4379269
    [No Abstract]   [Full Text] [Related]  

  • 31. Different patterns of autonomic nerve activity produced by a polar vs. a neutral cardiac glycoside.
    Rebagay WR; Caldwell RW
    J Pharmacol Exp Ther; 1990 Apr; 253(1):180-4. PubMed ID: 2329504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Resorption of alpha-acetyldigoxin and beta-acetyldigoxin studied by ECG].
    Watzke K; Klepzig H
    Med Klin; 1972 Mar; 67(12):413-7. PubMed ID: 5022885
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of microsomal enzyme inducers on the biliary excretion of cardiac glycosides.
    Klaassen CD
    J Pharmacol Exp Ther; 1974 Nov; 191(2):201-11. PubMed ID: 4418514
    [No Abstract]   [Full Text] [Related]  

  • 34. [Scillaglycosides].
    Haas H
    Med Klin; 1967 Jan; 62(4):121-6. PubMed ID: 4874199
    [No Abstract]   [Full Text] [Related]  

  • 35. [The pharmacology of cardiac glycosides].
    Noack E
    Med Klin; 1971 Apr; 66(16):583-6. PubMed ID: 4251818
    [No Abstract]   [Full Text] [Related]  

  • 36. [Affinity of various structured cardiac glycosides, DPH and Ro 2-2985 to the receptor of cardiac glycosides].
    Erdmann E; Schoner W
    Verh Dtsch Ges Kreislaufforsch; 1974; 40():309-14. PubMed ID: 4281217
    [No Abstract]   [Full Text] [Related]  

  • 37. [Therapy of chronic cardiac insufficiency with cardiac glycosides].
    Bonelli J
    Wien Med Wochenschr; 1982 Oct; 132(19):442-9. PubMed ID: 7179995
    [No Abstract]   [Full Text] [Related]  

  • 38. [Behavior of urinary secretion and plasma levels of various cardiac glycosides at the time of hospital admission].
    Ochs HR; Bodem G; Otten H; Meyer R; Baur MP
    Verh Dtsch Ges Inn Med; 1978; (84):749-52. PubMed ID: 742116
    [No Abstract]   [Full Text] [Related]  

  • 39. [On the tissue distribution, metabolism and excretion of cardiac glycosides].
    van Zwieten PA
    Dtsch Med Wochenschr; 1967 Sep; 92(37):1684-7. PubMed ID: 6054325
    [No Abstract]   [Full Text] [Related]  

  • 40. [Serum half-life and renal clearance of 3H peruvoside. Study on normal persons and patients with terminal kidney insufficiency].
    Kramer P; Willms B; Horenkamp J; Scheler F
    Verh Dtsch Ges Kreislaufforsch; 1969; 35():440-4. PubMed ID: 5380625
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.